Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
Tango Therapeutics, Inc.
Tango Therapeutics, Inc.
Seagen Inc.
Compass Therapeutics
National Institutes of Health Clinical Center (CC)
Tango Therapeutics, Inc.
Instituto do Cancer do Estado de São Paulo
Vastra Gotaland Region
Genmab
KaliVir Immunotherapeutics
Fudan University
Beijing Biotech
IDEAYA Biosciences
Vivace Therapeutics, Inc
AstraZeneca
iOnctura
Sotio Biotech Inc.
Massachusetts General Hospital
National Institutes of Health Clinical Center (CC)